Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia

Publication date: Available online 18 August 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Hayri Bostan, Tayfur Toptas, Funda Pepedil Tanrikulu, Kevser Kut, Fatma Arikan, Fergun Yilmaz, Isik Atagunduz, Tulin Firatli-Tuglular
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research